Zhejiang NHU stock
Price history
+3.91% over the period1 year: from ¥24.80 (November 18, 2025) to ¥25.77 (November 18, 2026), +3.91%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 18, 2026 | ¥25.77 |
| October 30, 2026 | ¥25.60 |
| September 30, 2026 | ¥25.95 |
| August 31, 2026 | ¥27.02 |
| July 31, 2026 | ¥30.01 |
| June 30, 2026 | ¥28.42 |
| May 29, 2026 | ¥29.37 |
| April 30, 2026 | ¥34.80 |
| March 31, 2026 | ¥34.55 |
| February 27, 2026 | ¥31.50 |
| January 30, 2026 | ¥27.86 |
| December 31, 2025 | ¥25.19 |
| November 28, 2025 | ¥24.38 |
| November 18, 2025 | ¥24.80 |
At a glance
The company
Produces nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients for animal and human nutrition, personal care, and industrial applications
Latest results
Quarter to September 30, 2026 · EPS ¥0.60 (estimate ¥0.83)
Next event
TickerLandia's take on Zhejiang NHU
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 12 vs a median of 18 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 11 vs 29 (−62%) in a group of 11.
- Strong point: Profitability (71/100 in its group). Weak point: Market momentum (40/100).
- “Undervalued quality stocks” (China): No. 1 of 3.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−35.88% from the 52-week high
Analysts · 12 analysts
Average target¥32.34+25.48% vs. price
Buy 8 · Hold 3 · Sell 1 · Buy
TickerLandia Fingerprint: Zhejiang NHU
Compared with similar companies: low price, high profitability, and high financial strength.
Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricelow22
How much it costs relative to what it produces.
Metric Value Position in group Price/book 2.15 38 Forward P/E 9.81 7 Price/sales 3.16 53 EV/EBITDA 6.99 4 P/E (trailing 12 months) 10.9 7 Profitabilityhigh71
How much it earns on revenue and capital.
Metric Value Position in group ROA 11.1% 83 Operating margin 33.8% 86 ROE 21.3% 86 Gross margin 42.9% 12 Net margin 29.4% 88 Earnings stabilityaverage44
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 6.1% 25 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthaverage60
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +10.12% 45 Earnings growth (year over year) +7.17% 63 Average revenue growth (3 years) +11.77% 72 Financial strengthhigh69
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.06 69 Interest coverage 34.4 65 Debt/equitycounts in reverse: lower means more financial strength 0.21 65 Current ratio 3.08 75 Dividendhigh64
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 33.6% 42 Consecutive dividend years at least 22 years 59 Dividend yield 3.8% 92 Market momentumaverage40
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +3.91% 48 Distance from 200-day average −14.23% 33 Risklow39
How much the price swings.
Metric Value Position in group Volatility (60 days) 25.9% 23 Maximum drawdown (12 months) 36.4% 55
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Zhejiang NHU is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Zhejiang NHU's P/E today is 11.7, below the median of its last 10 fiscal years (18.1; between 10.5 and 24.3 from 2016 to 2025). Zhejiang NHU's P/E (trailing 12 months): 10.9, −62% against the median of a group of 11 similar companies (28.8).
Compared with 11 similar companies
| Metric | Zhejiang NHU | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 10.9 | Low | |
| Forward P/E | 9.81 | Low | |
| Operating margin | 33.8% | High | |
| ROE | 21.3% | High | |
| Debt/equity | 0.21 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Zhejiang NHU. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥6.1B
Latest quarter · Q3 2026
Net income
¥1.86B
Latest quarter · Q3 2026
Quarterly net margin
30.4%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥82.05B
- P/E
- 10.9
- EPS
- ¥2.38
- Volume
- 24.19M
- Daily trading
- €75.37M
How Zhejiang NHU is changing
All resultsRevenue grew 16.6% a year on average over the last 5 years
Operating margin rose from 25.8% to 34.5%
Free cash flow equal to 85% of net income
Returns
Zhejiang NHU returns with dividends
¥1,000 invested in Zhejiang NHU 5 years ago, on November 18, 2021, would be worth ¥1,203 today with dividends reinvested: +20.30% in total, +3.77% per year. On price alone it would be ¥1,030 (+3.05%).
| Period | Zhejiang NHU | ¥1,000 becomes |
|---|---|---|
| 1 month | −1.60% | ¥984 |
| 6 months | −18.81% | ¥812 |
| Year to date | +2.30% | ¥1,023 |
| 1 year | +6.68% | ¥1,067 |
| 3 years | +69.82% | ¥1,698 |
| 5 years | +20.30% | ¥1,203 |
| 10 years | +293.23% | ¥3,932 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Zhejiang NHU: technical analysis
Zhejiang NHU shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 34.4% below its all-time closing high (¥39.30, March 12, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 48
- Between 30 and 70
- vs 200-session average
- −14.23%
Support and resistance
Price areas where Zhejiang NHU has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥27.58+7.01%3 touches, last on September 10, 2026
- Resistance¥27.05+4.98%3 touches, last on November 6, 2026
- Resistance¥26.05+1.09%5 touches, last on September 16, 2026
- Last price¥25.77
- Support¥24.96−3.15%5 touches, last on November 2, 2026
- Support¥23.81−7.61%2 touches, last on December 16, 2025
Volatility and risk
- Volatility (60 sessions, annualised)
- 25.9%
- Largest fall in the last year
- −36.39%
In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Zhejiang NHU: seasonality
Average monthly price change over 23 years
Over the last 23 years, the strongest month for Zhejiang NHU has been February: +9.28% on average, positive in 16 years out of 22. The weakest has been June: −1.91% on average, positive in 10 years out of 22. November, the current month, has been positive in 12 years out of 22 (+4.09% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.14% | −0.75% | 11 of 22 |
| February | +9.28% | +7.65% | 16 of 22 |
| March | +1.59% | +2.13% | 11 of 22 |
| April | +0.68% | +0.29% | 12 of 22 |
| May | +0.30% | −2.11% | 8 of 22 |
| June | −1.91% | −1.69% | 10 of 22 |
| July | +3.83% | +5.41% | 15 of 23 |
| August | +0.54% | +1.05% | 12 of 23 |
| September | +2.78% | −1.25% | 10 of 23 |
| October | +1.46% | −0.49% | 9 of 23 |
| November | +4.09% | +1.74% | 12 of 22 |
| December | +2.73% | +0.20% | 11 of 22 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Zhejiang NHU and its competitors
Sales reach customers across China and in export markets abroad. The group operates through pharmaceutical and chemical segments, and its products include nutrition products, flavors and fragrances, high-performance polymers, and active pharmaceutical ingredients. Animal feed producers buy vitamins, amino acids and carotenoids for poultry, pigs, ruminants and farmed fish, while supplement and personal care makers use vitamins, coenzyme Q10 and taurine. Fragrance houses draw on fruity, floral and herbal compounds, and industrial buyers take chemical intermediates for construction chemicals, crop protection and fertilizers.
- Headquarters
- Xinchang, China
- Employees
- 11,508
- Founded
- 1999
- Chief executive
- Bai Shan Hu
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Zhejiang NHU002001 | $12.31B | 33.8% | 10.9 | −18.81% |
| CiplaCIPLA | $12.03B | 13.0% | 38.8 | −3.08% |
| Zydus LifesciencesZYDUSLIFE | $12.85B | 17.2% | 28.8 | +19.03% |
| Laurus LabsLAURUSLABS | $14.01B | 24.1% | 97.8 | +76.64% |
| Yunnan Baiyao Group000538 | $15.07B | 11.2% | 19.3 | +10.79% |
| Eisai4523 | $9.34B | 5.7% | 33.9 | +19.33% |
Same industry or related industries, similar size. Compare Zhejiang NHU with its competitors · Full profile
